Debra Odink
2014
In 2014, Debra Odink earned a total compensation of $633.3K as Chief Technology Officer at Anthera Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $108,010 |
|---|---|
| Option Awards | $172,508 |
| Salary | $340,000 |
| Stock Awards | $12,750 |
| Total | $633,268 |
Odink received $340K in salary, accounting for 54% of the total pay in 2014.
Odink also received $108K in non-equity incentive plan, $172.5K in option awards and $12.8K in stock awards.
Rankings
In 2014, Debra Odink's compensation ranked 9,463rd out of 13,032 executives tracked by ExecPay. In other words, Odink earned more than 27.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,463 out of 13,032 | 27th |
Division Manufacturing | 3,569 out of 4,965 | 28th |
Major group Chemicals And Allied Products | 1,220 out of 1,690 | 28th |
Industry group Drugs | 966 out of 1,369 | 29th |
Industry Pharmaceutical Preparations | 739 out of 1,042 | 29th |
Source: SEC filing on April 9, 2015.
Odink's colleagues
We found six more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2014.
2014
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2014
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2014
May Liu
Anthera Pharmaceuticals
SVP, Finance & Administration
2014
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2014
Klara Dickinson
Anthera Pharmaceuticals
Senior Vice President Chief Regulatory Officer
2014
Klara Dickinson-Eason
Anthera Pharmaceuticals